Australia's Anteotech tracks best day in 15 months on Europe nod for COVID test

Anteotech

18/05/2022 02:26

** Shares of Anteotech  ADO.AX  soar as much as 59.6% to
A$0.15 - set for best session since February 2021, if gains hold
    ** Nanotechnology firm says its updated EuGeni COVID-19
Rapid Antigen Test got regulatory approval in Europe  urn:newsml:reuters.com:*:nASX9Xp2r
    ** Stock hits its highest since April 20 
    ** 13.2 mln shares change hands, compared with the 30-day
average of 4.1 mln shares 
    ** Stock down 69.2% this year, as of last close 
    


 (Reporting by Navya Mittal in Bengaluru)
 ((navya.mittal@thomsonreuters.com))